Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Alarcan

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|August 19, 2020
Effects of Ischemia-Reperfusion on Tubular Cell Membrane Transporters and Consequences in Kidney TransplantationQuentin Faucher, Hugo Alarcan, Pierre Marquet, et al.
Clinical Chemistry|April 13, 2023
A Negative Internal Standard in Urinary Metanephrines QuantificationHugo Alarcan, Arthur Wilhelm, Colette Faideau, et al.
British Journal of Clinical Pharmacology|December 12, 2022
Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposureHugo Alarcan, Pauline Cannet, Vincent Camus, et al.
Nutrients|December 11, 2025
Exploration of Homocysteine Metabolism and Genetics in Autism Spectrum DisorderMelissa Rouphael, Tania Bitar, Hugo Alarcan, et al.
Annales De Biologie Clinique|July 7, 2022
Triad of diabetic ketoacidosis-acute pancreatitis-hypertriglyceridaemia: interest of genetic explorationHugo Alarcan, Antoine Guillon, François Maillot, et al.
Therapie|February 28, 2022
[Therapeutic drug monitoring of cyamemazine: How to interpret a concentration? A review of literature]Hugo Alarcan, David Schnell, Stéphane Rouleau, et al.
Talanta|September 26, 2022
Validation of metabolomic and lipidomic analyses of human tears using ultra-high-performance liquid chromatography tandem mass spectrometrySophie Catanese, Raoul K Khanna, Antoine Lefevre, et al.
European Journal of Neurology|March 12, 2023
Evaluation of arterial blood gas parameters as prognostic markers in amyotrophic lateral sclerosisHugo Alarcan, Camille Cotet, Nadège Lépine, et al.
Biodata Mining|June 26, 2026
Learning a distance for the clustering of patients with amyotrophic lateral sclerosisGuillaume Tejedor Y Dominguez, Hugo Alarcan, Veronika Peralta, et al.
Expert Opinion on Therapeutic Targets|June 2, 2022
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic targetYara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|August 19, 2020
Effects of Ischemia-Reperfusion on Tubular Cell Membrane Transporters and Consequences in Kidney TransplantationQuentin Faucher, Hugo Alarcan, Pierre Marquet, et al.
Clinical Chemistry|April 13, 2023
A Negative Internal Standard in Urinary Metanephrines QuantificationHugo Alarcan, Arthur Wilhelm, Colette Faideau, et al.
British Journal of Clinical Pharmacology|December 12, 2022
Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposureHugo Alarcan, Pauline Cannet, Vincent Camus, et al.
Nutrients|December 11, 2025
Exploration of Homocysteine Metabolism and Genetics in Autism Spectrum DisorderMelissa Rouphael, Tania Bitar, Hugo Alarcan, et al.
Annales De Biologie Clinique|July 7, 2022
Triad of diabetic ketoacidosis-acute pancreatitis-hypertriglyceridaemia: interest of genetic explorationHugo Alarcan, Antoine Guillon, François Maillot, et al.
Therapie|February 28, 2022
[Therapeutic drug monitoring of cyamemazine: How to interpret a concentration? A review of literature]Hugo Alarcan, David Schnell, Stéphane Rouleau, et al.
Talanta|September 26, 2022
Validation of metabolomic and lipidomic analyses of human tears using ultra-high-performance liquid chromatography tandem mass spectrometrySophie Catanese, Raoul K Khanna, Antoine Lefevre, et al.
European Journal of Neurology|March 12, 2023
Evaluation of arterial blood gas parameters as prognostic markers in amyotrophic lateral sclerosisHugo Alarcan, Camille Cotet, Nadège Lépine, et al.
Biodata Mining|June 26, 2026
Learning a distance for the clustering of patients with amyotrophic lateral sclerosisGuillaume Tejedor Y Dominguez, Hugo Alarcan, Veronika Peralta, et al.
Expert Opinion on Therapeutic Targets|June 2, 2022
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic targetYara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, et al.
Pageof 3